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We have found that the 14-3-3 protein, an acidic neuronal protein, is substantially identical to the 'activator' 
protein [(1981) J. Biol. Chem. 256, 5404-5409] that activates tryptophan 5-monooxygenase and tyrosine 
3-monooxygenase in the presence of Ca 2 +,calmodulin dependent protein kinase II. This finding is based 
on the remarkable similarity of both these proteins in physicochemical, biochemical nd immunochemical 
properties, as welt as on detection for the 14-3-3 protein of an activator activity towards tryptophan 5- 
monooxygenase. The result suggests that the 14-3-3 protein plays a role in the regulation of serotonin and 
noradrenaline biosynthesis in brain. 
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1. INTRODUCTION 
The 14-3-3 protein is a soluble acidic protein 
originally designated by Moore and Perez [1]. This 
protein is distributed abundantly in brain tissue 
(about 1% of brain soluble proteins), while it is 
also found in other tissues such as testis and in- 
testine at lower concentrations [2]. Within brain 
tissue, the protein is localized specifically in 
neurons [3], and is subject to axonal transport in 
the retinal ganglion cells [4]. Biochemical studies 
showed that the 14-3-3 protein had a molecular 
mass of 50 kDa [4] or 67 kDa [3] consisting of two 
dissimilar 25 kDa subunits [5] or 29 and 32 kDa 
subunits [3]. It has been shown that the 14-3-3 pro- 
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tein isolated from human [3] and bovine [5] brain 
is heterogeneous in containing two closely related 
molecular species having different subunit com- 
position [3]. However, the functional significance 
of this neuronal protein is unknown. 
As part of our program of systematic studies on 
acidic brain proteins [6-10], we purified the 14-3-3 
protein from bovine brain and characterized it by 
amino acid analysis and peptide mapping [11]. In 
the course of this study we noticed that the amino 
acid composition of the 14-3-3 protein is 
remarkably similar to the published composition 
of the activator protein [12] that has previously 
been isolated as a protein factor which activates 
tryptophan 5-monooxygenase and tyrosine 3- 
monooxygenase in the presence of Ca 2÷, cal- 
modulin-dependent protein kinase II (kinase II). 
Further biochemical and immunochemical studies 
have provided evidence that this neuronal protein 
is in fact identical to the activator protein, sug- 
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gesting a role for the 14-3-3 protein in the regula- 
tion of catecholamine and indolamine synthesis in 
neurons and other non-neuronal cells. 1 
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2. MATERIALS AND METHODS 
The bovine brain 14-3-3 protein was prepared by 
a procedure similar to that described for the 
purification of neuron specific enolase [9]. In a 
final purification step on DEAE-Sephadex A-50, 
the 14-3-3 protein was eluted following the enolase 
as noted in previous papers [3,5]. An antiserum 
against the 14-3-3 protein was produced in 
BALB/c mice by serial injections of the purified 
antigen (50 ttg/50/A) mixed with an equal volume 
of Freund's complete adjuvant. A preliminary 
report on the purification and characterization of
purified 14-3-3 protein has been presented [11], 
details will be published elsewhere. Rat brain ac- 
tivator protein was purified as in [12]. Tryptophan 
5-monooxygenase (EC 1.14.16.4) was prepared 
from rat brain stem as in [12]. Kinase II was 
purified from rat cerebral cortex as in [13]. 
Activator protein was assayed on the basis of its 
ability to activate tryptophan 5-monooxygenase in 
the presence of excess amounts of kinase II [12]. 
SDS-polyacrylamide (10%) gel electrophoresis in
micro slab gels and subsequent immunoblot 
analysis were carried out as in [14]. The amino acid 
composition was determined as in [8] after 
hydrolysis of protein samples with 6 M HCI in 
evacuated, sealed tubes. 
3. RESULTS 
The 14-3-3 protein, isolated from bovine brain, 
showed molecular characteristics very similar to 
those described in previous papers [3-5]; i.e. an 
acidic isoelectric point (4.7-5.3), a molecular mass 
estimated in the absence of denaturating agents 
(55 kDa), subunit composition (two distinct 
polypeptides in SDS-polyacrylamide gel elec- 
trophoresis; see fig.l), amino acid composition 
(table 1), and a blocked N-terminus. The rather 
wide range of pI  values of the 14-3-3 protein may 
reflect the reported heterogeneity of this protein 
[3]. The rat brain activator protein, on the other 
hand, was characterized in [12]. It was shown to be 
an acidic, dimeric protein (70 kDa) composed of 
two 35 kDa subunits. 
A B 
Fig.1. (A) SDS-polyacrylamide g l electrophoresis and 
(B) immunoblot analysis of the bovine brain 14-3-3 (lane 
1) and rat brain activator (lane 2) proteins. (A) 
Coomassie blue staining and (B) immunoperoxidase 
staining using a mouse antiserum against bovine brain 
14-3-3 protein. 
We first noticed a possible relationship between 
the 14-3-3 and activator proteins in the similarity 
of their amino acid compositions. As shown in 
table 1, the composition of the bovine brain 14-3-3 
protein determined in this study or of the human 
equivalent presented by Boston et al. [2] exhibited 
very good coincidence (correlation coefficient; 
0.97) with the published composition of the ac- 
tivator protein from rat brain [12]. The acidic and 
dimeric nature of the 14-3-3 protein, the molecular 
size of subunits, as well as its high content in brain 
tissue, also fit the reported characteristics of the 
activator protein. 
For a more direct comparison of both these pro- 
teins we purified the activator protein from rat 
brain as described [12] and analyzed the 14-3-3 and 
activator proteins in parallel by SDS-polyacryl- 
amide gel electrophoresis. As shown in fig.la, 
these proteins gave rise to a very similar elec- 
trophoresis pattern; there are two distinct polypep- 
tides in which the major faster migrating poly- 
peptide accounted for approx. 90°7o of the total 
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Table 1 
Amino acid composition of the 14-3-3 and activator 
proteins 
Amino acid 14-3-3 
Bovine Human 
Rat 
activator 
[31 [12] 
Lys 8.1 9.3 7.7 
His 0.9 0.8 0.8 
Arg 4.9 4.8 5.0 
Asp 11.9 11.9 12.0 
Thr 4.3 4.4 4.0 
Ser 6.3 6.4 6.7 
Glu 18.2 18.3 16.5 
Pro 2.2 1.9 2.3 
Gly 4.6 4.2 4.4 
Ala 10.1 9.8 10.0 
Cys n.d. n.d. 1.4 
Val 5.4 3.8 5.1 
Met 2.8 2.9 2.8 
Ile 3.8 4.1 4.1 
Leu 9.7 10.3 10.1 
Tyr 4.6 4.6 4.6 
Phe 2.4 2.3 2.4 
Trp n.d. n.d. 0.8 
Results expressed as mol%. n.d., not determined 
protein (estimated from the Coomassie blue stain- 
ing). This is comparable to the observation of 
Boston et al. [3] that the human brain 14-3-3 pro- 
tein contained subunits of two different molecular 
mass class, 29 kDa and 32 kDa, at a relative con- 
tent of 9 : 1. In addition, these polypeptides of the 
activator protein reacted with an antiserum against 
the 14-3-3 protein in a subsequent immunoblot 
analysis on a nitrocellulose sheet (fig.lb). Thus, 
the 14-3-3 protein shares various physicochemical 
and immunochemical properties in common with 
the activator protein. 
We have finally examined whether the 14-3-3 
protein has an activator activity towards tryp- 
tophan 5-monooxygenase. As noted in [15], tryp- 
tophan 5-monooxygenase was activated by kinase 
II only in the presence of the activator protein 
(fig.2). The concentration of activator protein re- 
quired for half-maximal ctivation of the monoox- 
ygenase was about 1/zg/ml. The bovine brain 
14-3-3 protein added into the assay mixture in 
place of the activator protein was also effective in 
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Fig.2. Effect of varying the concentration of the rat 
brain activator (©) and bovine brain 14-3-3 (e) proteins 
on activity of tryptophan 5-monooxygenase. The 
activity of tryptophan 5-monooxygenase (l.4/zg of 
protein) was assayed with different amounts of 14-3-3 or 
activator protein under conditions described in [12]. 
Control experiments ( . . . )  were performed with a 
complete assay system without kinase II. One unit of 
tryptophan 5-monooxygenase i  defined as the amount 
which catalyzes the formation of 1 nmol 5-hydroxytryp- 
tophan/min at 30°C. 
the kinase dependent activation of tryptophan 
5-monooxygenase (fig.2). The concentration of the 
14-3-3 protein required for the half-maximal ac- 
tivation was about 2.5/zg/ml. 
4. DISCUSSION 
Since the first description of the 14-3-3 protein 
in 1967, the biological significance of this neuronal 
protein has been the subject of investigation. For 
instance, Boston et al. [3] screened the 14-3-3 pro- 
tein for various enzymatic activities and made at- 
tempts to correlate with brain cytoskeletal 
elements, both with negative results. We deter- 
mined a portion of the amino acid sequence, and 
the sequence was subjected to computer-assisted 
analysis for the search of homologies to other 
known proteins using the PIR-NBRF database. 
However no significant homology was detectable 
81 
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through the computer programs we used. We an- 
ticipated, therefore, that the 14-3-3 protein would 
be unique in its amino acid sequence and also in 
biological function. 
In this report we have shown that the bovine 
brain 14-3-3 protein activates tryptophan 
5-monooxygenase in the presence of kinase II. This 
fact, together with a remarkable similarity in 
physicochemical parameters and a common im- 
munochemical reactivity, indicates that the 14-3-3 
protein is identical to the protein activator an 
essential factor for the kinase-dependent activation 
of tryptophan 5-monooxygenase and tyrosine 
3-monooxygenase [ 12,13]. The bovine brain 14-3-3 
protein and rat brain activator exhibited slightly 
different specific activities in activating tryptophan 
5-monooxygenase (fig.2), we assume that this may 
be a species-specific event raised by our experiment 
in which the rat assay system was employed for the 
bovine protein, although further experiments are 
needed to clarify this point. 
Tryptophan 5-monooxygenase and tyrosine 
3-monooxygenase are rate-limiting enzymes in in- 
dolamine and catecholamine biosynthesis, respec- 
tively, and are known to be the targets of various 
regulatory factors including kinase II or/and 
cAMP-dependent protein kinase. In the tyrosine 
3-monooxygenase-cAMP-dependent ki ase sys- 
tem, the activation of monooxygenase occurs 
directly by the phosphorylation without additional 
protein factors [15]. It is interesting, therefore, 
that kinase II requires the 14-3-3 or activator pro- 
tein for the activation of these monooxygenases 
not only with respect o its biological significance 
but also with respect to its molecular mechanism of 
action. Yamauchi and Fujisawa [15] have reported 
that the kinase II dependent activation of the 
monooxygenases involves two step processes, 
phosphorylation of the monooxygenases and ac- 
tivation of the phosphorylated monooxygenases, 
and that the latter process requires the activator 
protein. 
It should also be noted that the 14-3-3 activator 
is present in brain tissue in extraordinarily high 
concentration (13.3/zg/mg soluble protein [2]). 
Although brain has the highest concentration, the 
radioimmunoassay [2] and the activity measure- 
ment [12] have detected lower levels of this protein 
in almost all tissues including such tissues where 
the activities of the monooxygenase are not detect- 
able at a significant level. Thus, the cellular 
distribution of the 14-3-3 protein does not appear 
to parallel the distribution of the monooxygenases. 
These observations, together with an apparent 
heterogeneity of this protein, suggest that the 
14-3-3 protein may be involved not only in the 
regulation of serotonin and noradrenaline biosyn- 
thesis but also in other biological processes in 
neurons and other non-neuronal cells. 
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